Meyerson M - Search Results

1

Oncogenic RIT1 mutations in lung adenocarcinoma.

Berger AH, Imielinski M, Duke F, Wala J, Kaplan N, Shi GX, Andres DA, Meyerson M. Berger AH, et al. Among authors: meyerson m. Oncogene. 2014 Aug 28;33(35):4418-23. doi: 10.1038/onc.2013.581. Epub 2014 Jan 27. Oncogene. 2014. PMID: 24469055 Free PMC article.

2

Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase.

Counter CM, Meyerson M, Eaton EN, Ellisen LW, Caddle SD, Haber DA, Weinberg RA. Counter CM, et al. Among authors: meyerson m. Oncogene. 1998 Mar 5;16(9):1217-22. doi: 10.1038/sj.onc.1201882. Oncogene. 1998. PMID: 9528864

3

Missense mutations of the BRAF gene in human lung adenocarcinoma.

Naoki K, Chen TH, Richards WG, Sugarbaker DJ, Meyerson M. Naoki K, et al. Among authors: meyerson m. Cancer Res. 2002 Dec 1;62(23):7001-3. Cancer Res. 2002. PMID: 12460919

4

Molecular classification and molecular genetics of human lung cancers.

Meyerson M, Franklin WA, Kelley MJ. Meyerson M, et al. Semin Oncol. 2004 Feb;31(1 Suppl 1):4-19. doi: 10.1053/j.seminoncol.2003.12.009. Semin Oncol. 2004. PMID: 14981576 Review.

5

High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines.

Jänne PA, Li C, Zhao X, Girard L, Chen TH, Minna J, Christiani DC, Johnson BE, Meyerson M. Jänne PA, et al. Among authors: meyerson m. Oncogene. 2004 Apr 8;23(15):2716-26. doi: 10.1038/sj.onc.1207329. Oncogene. 2004. PMID: 15048096

6

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M. Paez JG, et al. Among authors: meyerson m. Science. 2004 Jun 4;304(5676):1497-500. doi: 10.1126/science.1099314. Epub 2004 Apr 29. Science. 2004. PMID: 15118125

7

Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants.

Greulich H, Chen TH, Feng W, Jänne PA, Alvarez JV, Zappaterra M, Bulmer SE, Frank DA, Hahn WC, Sellers WR, Meyerson M. Greulich H, et al. Among authors: meyerson m. PLoS Med. 2005 Nov;2(11):e313. doi: 10.1371/journal.pmed.0020313. Epub 2005 Oct 4. PLoS Med. 2005. PMID: 16187797 Free PMC article.

8

Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor.

Alvarez JV, Greulich H, Sellers WR, Meyerson M, Frank DA. Alvarez JV, et al. Among authors: meyerson m. Cancer Res. 2006 Mar 15;66(6):3162-8. doi: 10.1158/0008-5472.CAN-05-3757. Cancer Res. 2006. PMID: 16540667

9

Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors.

Ji H, Zhao X, Yuza Y, Shimamura T, Li D, Protopopov A, Jung BL, McNamara K, Xia H, Glatt KA, Thomas RK, Sasaki H, Horner JW, Eck M, Mitchell A, Sun Y, Al-Hashem R, Bronson RT, Rabindran SK, Discafani CM, Maher E, Shapiro GI, Meyerson M, Wong KK. Ji H, et al. Among authors: meyerson m. Proc Natl Acad Sci U S A. 2006 May 16;103(20):7817-22. doi: 10.1073/pnas.0510284103. Epub 2006 May 3. Proc Natl Acad Sci U S A. 2006. PMID: 16672372 Free PMC article.

10

"Lineage addiction" in human cancer: lessons from integrated genomics.

Garraway LA, Weir BA, Zhao X, Widlund H, Beroukhim R, Berger A, Rimm D, Rubin MA, Fisher DE, Meyerson ML, Sellers WR. Garraway LA, et al. Among authors: meyerson ml. Cold Spring Harb Symp Quant Biol. 2005;70:25-34. doi: 10.1101/sqb.2005.70.016. Cold Spring Harb Symp Quant Biol. 2005. PMID: 16869735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

557 results

Search Page